BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30385085)

  • 1. Clinical and histopathological significance of PD-1 expression in cutaneous lesions of adult T-cell leukemia-lymphoma.
    Higuchi M; Kuwatsuka Y; Murota H; Iwanaga M; Niino D
    Pathol Res Pract; 2019 Jan; 215(1):40-49. PubMed ID: 30385085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult T-cell leukemia/lymphoma (ATL) presenting in the skin: clinical, histological and immunohistochemical features of 52 cases.
    Bittencourt AL; Barbosa HS; Vieira MD; Farré L
    Acta Oncol; 2009; 48(4):598-604. PubMed ID: 19165640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia/lymphoma.
    Sawada Y; Hino R; Hama K; Ohmori S; Fueki H; Yamada S; Fukamachi S; Tajiri M; Kubo R; Yoshioka M; Nakashima D; Sugita K; Yoshiki R; Shimauchi T; Mori T; Izu K; Kobayashi M; Nakamura M; Tokura Y
    Blood; 2011 Apr; 117(15):3961-7. PubMed ID: 21325600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin manifestations of adult T-cell leukemia/lymphoma: clinical, cytological and immunological features.
    Tokura Y; Sawada Y; Shimauchi T
    J Dermatol; 2014 Jan; 41(1):19-25. PubMed ID: 24438140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological features of cutaneous lesions of adult T-cell leukaemia/ lymphoma.
    Yamaguchi T; Ohshima K; Karube K; Tutiya T; Kawano R; Suefuji H; Shimizu A; Nakayama J; Suzumiya J; Moroi Y; Urabe K; Furue M; Koga T; Kikuchi M
    Br J Dermatol; 2005 Jan; 152(1):76-81. PubMed ID: 15656804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meeting report on the possible proposal of an extranodal primary cutaneous variant in the lymphoma type of adult T-cell leukemia-lymphoma.
    Tsukasaki K; Imaizumi Y; Tokura Y; Ohshima K; Kawai K; Utsunomiya A; Amano M; Watanabe T; Nakamura S; Iwatsuki K; Kamihira S; Yamaguchi K; Shimoyama M
    J Dermatol; 2014 Jan; 41(1):26-8. PubMed ID: 24438141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: a single-center, retrospective study.
    Marchetti MA; Pulitzer MP; Myskowski PL; Dusza SW; Lunning MA; Horwitz SM; Moskowitz AJ; Querfeld C
    J Am Acad Dermatol; 2015 Feb; 72(2):293-301. PubMed ID: 25455841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma. Clinical, histopathologic, and immunohistochemical analyses.
    Nagatani T; Matsuzaki T; Iemoto G; Kim S; Baba N; Miyamoto H; Nakajima H
    Cancer; 1990 Dec; 66(11):2380-6. PubMed ID: 2245393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmented expression of programmed death-1 in both neoplastic and non-neoplastic CD4+ T-cells in adult T-cell leukemia/lymphoma.
    Shimauchi T; Kabashima K; Nakashima D; Sugita K; Yamada Y; Hino R; Tokura Y
    Int J Cancer; 2007 Dec; 121(12):2585-90. PubMed ID: 17721918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed death-1 expression in cutaneous B-cell lymphoma.
    Çetinözman F; Koens L; Jansen PM; Willemze R
    J Cutan Pathol; 2014 Jan; 41(1):14-21. PubMed ID: 24151955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of programmed death-1 in cutaneous extranodal natural killer/T-cell lymphoma and its effect on clinical findings and biological behaviour.
    Kim YJ; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
    J Eur Acad Dermatol Venereol; 2017 May; 31(5):821-827. PubMed ID: 28190256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases.
    Klemke CD; Booken N; Weiss C; Nicolay JP; Goerdt S; Felcht M; Géraud C; Kempf W; Assaf C; Ortonne N; Battistella M; Bagot M; Knobler R; Quaglino P; Arheiliger B; Santucci M; Jansen P; Vermeer MH; Willemze R
    Br J Dermatol; 2015 Jul; 173(1):93-105. PubMed ID: 25864856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma.
    Cetinözman F; Jansen PM; Willemze R
    Am J Surg Pathol; 2012 Jan; 36(1):109-16. PubMed ID: 21989349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of thymus and activation-regulated chemokine and macrophage-derived chemokine by CCR4+ adult T-cell leukemia cells.
    Shimauchi T; Imai S; Hino R; Tokura Y
    Clin Cancer Res; 2005 Mar; 11(6):2427-35. PubMed ID: 15788694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1, S-100 and CD1a expression in pseudolymphomatous folliculitis, primary cutaneous marginal zone B-cell lymphoma (MALT lymphoma) and cutaneous lymphoid hyperplasia.
    Goyal A; Moore JB; Gimbel D; Carter JB; Kroshinsky D; Ferry JA; Harris NL; Duncan LM
    J Cutan Pathol; 2015 Jan; 42(1):6-15. PubMed ID: 25384543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T-lymphotropic virus type I proviral loads in patients with adult T-cell leukemia-lymphoma: Comparison between cutaneous type and other subtypes.
    Yonekura K; Utsunomiya A; Seto M; Takatsuka Y; Takeuchi S; Tokunaga M; Kubota A; Takeda K; Kanzaki T; Uchida Y; Kawai K; Kanekura T
    J Dermatol; 2015 Dec; 42(12):1143-8. PubMed ID: 26134467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma.
    Nagatani T; Miyazawa M; Matsuzaki T; Iemoto G; Kim ST; Baba N; Miyamoto H; Nakajima H
    Semin Dermatol; 1994 Sep; 13(3):216-22. PubMed ID: 7986691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic analysis of 124 cases of adult T-cell leukemia/lymphoma with cutaneous manifestations: the smouldering type with skin manifestations has a poorer prognosis than previously thought.
    Setoyama M; Katahira Y; Kanzaki T
    J Dermatol; 1999 Dec; 26(12):785-90. PubMed ID: 10659498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
    Nguyen GH; Olson LC; Magro CM
    Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of programmed death-1 (CD279) in primary cutaneous B-cell lymphomas with correlation to lymphoma entities and biological behaviour.
    Mitteldorf C; Bieri M; Wey N; Kerl K; Kamarachev J; Pfaltz M; Kutzner H; Roncador G; Tomasini D; Kempf W
    Br J Dermatol; 2013 Dec; 169(6):1212-8. PubMed ID: 23937075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.